by Manon FRACHON | 2 Jun Mon | Without category
Pascal Touchon will reinforce Jeito’s expertise by bringing over 35 years of global experience in drug development, commercial activities, operational and strategic leadership at major international pharmaceutical groups and biotech companies. He will support... by Manon FRACHON | 21 May Wed | Without category
Proceeds from the financing will advance ReproNovo’s lead candidates RPN-001 (leflutrozole) and RPN-002 (nolasiban), through Phase 2 clinical trials in male infertility and in the treatment of adenomyosis and embryo implantation, respectively. In the context of...
Recent Comments